| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2083518 | European Journal of Pharmaceutics and Biopharmaceutics | 2014 | 9 Pages |
•Development of film-coated tablets for colon targeting.•Mixtures of Chitosan (CHI) and Kollicoat (KCSS) used as coating material.•Ludiflash tablets (LTs) and microcrystalline cellulose tablets (MTs) used as cores.•Pressure-controlled drug release of CHI/KCSS (25:75) coated LTs.•Enzymatically triggered drug release of CHI and CHI/KCSS (25:75) coated MTs.
The aim of the present study was to develop film-coated tablets which release a minor amount of the active pharmaceutical ingredient (API) into the stomach and small intestine, yet show a sharp increase of drug release in the colon. Tablets containing the model drug Diclofenac-Na, microcrystalline cellulose as a filler (MT), as well as tablets consisting of Ludiflash® (LT), both were used as tablet cores, respectively. Either chitosan (CHI) alone or different ratios of chitosan and Kollicoat® Smartseal 30 D (KCSS) were applied onto these cores. The resulting film-coated tablets were analyzed for swelling, drug dissolution and stability. In order to clarify whether the colon release is mainly enzyme-driven or pressure-controlled, the coated tablets were both tested in the colon microflora test (CMT), which simulates the enzyme environment within the colon, and using a bio-relevant dissolution apparatus mimicking the intraluminal pressures and stress conditions present in the gastrointestinal tract (GIT). CHI/KCSS (25:75) coated LTs showed a pressure-controlled site-specific drug release in the large intestine, while remaining intact in the upper GIT. CHI as well as CHI/KCSS (25:75) applied onto MTs, remained stable during the entire simulated bio-relevant dissolution transit of the GIT, but showed enzymatically controlled colon targeting in the CMT. These results could be confirmed for CHI/KCSS (25:75) film-coated MTs top-coated with an additional hydroxypropylmethylcellulose (HPMC) layer and an Eudragit L 30 D-55 (EUL) layer to avoid the dissolution in the fasting stomach.
Graphical abstractFigure optionsDownload full-size imageDownload high-quality image (144 K)Download as PowerPoint slide
